Details
Stereochemistry | ACHIRAL |
Molecular Formula | C3H8O3 |
Molecular Weight | 92.0938 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCC(O)CO
InChI
InChIKey=PEDCQBHIVMGVHV-UHFFFAOYSA-N
InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2
Molecular Formula | C3H8O3 |
Molecular Weight | 92.0938 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Glycerin (glycerol) is 3-carbon alcohol naturally occurring in the human body. It is the structural backbone triacylglycerol molecules, and can also be converted to a glycolytic substrate for subsequent metabolism. Glycerin is a colorless, odorless, viscous, sweet-tasting liquid. The FDA classifies glycerol as "generally recognized as safe". Glycerin is used in the pharmaceutical industry as a sweetener in syrups, lozenges, and as an excipient in eyewash solutions. As an individual prescription product, glycerin has uses as a hyperosmotic, osmotic diuretic, and ophthalmic agent. It may be used as an eye drop in the treatment of glaucoma to reduce intraocular pressure, as a solution or suppository for short-term treatment of constipation, to evacuate the bowel prior to a colonoscopy, and in some ocular surgeries. It may be given intravenously to reduce pressure inside the brain and used externally on the skin as a moisturizer. Glycerin has many other uses in the agricultural, food and pharmaceutical industry.
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1770 mg/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8369006/ |
1.2 g/kg single, oral dose: 1.2 g/kg route of administration: Oral experiment type: SINGLE co-administered: |
GLYCERIN serum | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
39.3 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4300572/ |
120 mmol/m² single, intravenous dose: 120 mmol/m² route of administration: Intravenous experiment type: SINGLE co-administered: |
GLYCERIN serum | Homo sapiens population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
|
0.895 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8369006/ |
1.2 g/kg single, oral dose: 1.2 g/kg route of administration: Oral experiment type: SINGLE co-administered: |
GLYCERIN serum | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Doses
Dose | Population | Adverse events |
---|---|---|
310 g single, oral Overdose |
unhealthy, 72 years |
Other AEs: Agitation, Groaning... Other AEs: Agitation (1 patient) Sources: Groaning (1 patient) Speech loss (1 patient) |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Agitation | 1 patient | 310 g single, oral Overdose |
unhealthy, 72 years |
Groaning | 1 patient | 310 g single, oral Overdose |
unhealthy, 72 years |
Speech loss | 1 patient | 310 g single, oral Overdose |
unhealthy, 72 years |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Sources: https://pubmed.ncbi.nlm.nih.gov/9113273/ |
yes |
PubMed
Title | Date | PubMed |
---|---|---|
Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin. | 2001 |
|
Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress. | 2001 |
|
Strategy for preventing peritoneal dialysis failure. | 2001 |
|
Reversible vacuolation of T-tubules in skeletal muscle: mechanisms and implications for cell biology. | 2001 |
|
A comparison of F-actin labeling methods for light microscopy in different plant specimens: multiple techniques supplement each other. | 2001 Aug |
|
Isolation and characterization of mitochondrial F(1)-ATPase from crayfish (Orconectes virilis) gills. | 2001 Feb |
|
How water molecules pass through aquaporins. | 2001 Feb |
|
Chronic ingestion of ethanol stimulates lipogenic response in rat hepatocytes. | 2001 Feb 2 |
|
The yeast glycerol 3-phosphatases Gpp1p and Gpp2p are required for glycerol biosynthesis and differentially involved in the cellular responses to osmotic, anaerobic, and oxidative stress. | 2001 Feb 2 |
|
Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes. | 2001 Jan |
|
Lipid-dependent control of hepatic glycogen stores in healthy humans. | 2001 Jan |
|
Inhibition of a model protease--pyroglutamate aminopeptidase by a natural oligosaccharide gum from Hakea gibbosa. | 2001 Jan 16 |
|
Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family. | 2001 Jan 26 |
|
Rhamnolipid production by Pseudomonas aeruginosa under denitrification: effects of limiting nutrients and carbon substrates. | 2001 Jan 5 |
|
A rational approach to improving productivity in recombinant Pichia pastoris fermentation. | 2001 Jan 5 |
|
Erythrocyte water permeability and renal function in double knockout mice lacking aquaporin-1 and aquaporin-3. | 2001 Jan 5 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:35:08 GMT 2025
by
admin
on
Mon Mar 31 17:35:08 GMT 2025
|
Record UNII |
PDC6A3C0OX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
54283-7
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
FDA ORPHAN DRUG |
28188
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
JECFA EVALUATION |
GLYCEROL
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
JECFA EVALUATION |
INS-422
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-422
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
LOINC |
45300-1
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
WHO-VATC |
QA16QA03
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
LOINC |
54285-2
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
LOINC |
2388-7
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
LOINC |
2387-9
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
DSLD |
1110 (Number of products:309)
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
WHO-ATC |
A06AG04
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
CFR |
21 CFR 349.12
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
WHO-ATC |
A06AX01
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
LOINC |
54284-5
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
NCI_THESAURUS |
C29697
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
WHO-VATC |
QA06AG04
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
NDF-RT |
N0000185370
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
EPA PESTICIDE CODE |
63507
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
WHO-VATC |
QA06AX01
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
CFR |
21 CFR 347.10
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
||
|
LOINC |
47632-5
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID9020663
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
DB09462
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
N0000006566
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | Glycerol [Chemical/Ingredient] | ||
|
GLYCEROL
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
SUB07948MIG
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
SUB13992MIG
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
N0000171131
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
753
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
GLYCERIN
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | Description: A clear, colourless or almost colourless, syrupy liquid; odourless. Miscibility: Miscible with water and ethanol (~750 g/l) TS; slightly miscible with acetone R; practically immiscible with ether R. Category: Solvent; humectant.Storage: Glycerol should be kept in a tightly closed container. Additional information: Glycerol is hygroscopic. Requirement: Glycerol contains not less than 95.0% and not more than the equivalent of 101.0% of C3H8O3, calculated with reference to theanhydrous substance. | ||
|
PDC6A3C0OX
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
56-81-5
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
CHEMBL692
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
C29077
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
N0000184306
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
200-289-5
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
PDC6A3C0OX
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
1316
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
m5790
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | Merck Index | ||
|
444
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
N0000175629
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | Increased Histamine Release [PE] | ||
|
1295607
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
9230
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
4910
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | RxNorm | ||
|
D005990
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
N0000185001
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | Increased IgG Production [PE] | ||
|
492
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
17754
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY | |||
|
100000092821
Created by
admin on Mon Mar 31 17:35:08 GMT 2025 , Edited by admin on Mon Mar 31 17:35:08 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Glycerol (mg/cigarette)
Canadian = 13.2 SD(1.3)
Imported = 13.5 SD(0.0)
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (GC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|